Thermo Fisher Scientific to acquire CorEvitas for $912.5 million
Advances clinical research capabilities with leading regulatory grade registries platform
Advances clinical research capabilities with leading regulatory grade registries platform
The detailed terms in relation to the Rights Issue, including but not limited to the issue price, rights entitlement ratio, record date, timing and terms of payment will be determined in due course.
Ensitrelvir is an oral antiviral that suppresses the replication of SARS-CoV-2 by selectively inhibiting the viral 3CL protease.
The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective
India’s efforts are aimed at boosting health at the last mile
Cautions against fragmented & siloed efforts in addressing the challenges faced by the world and underlined the need for collaborative efforts to ensure global health security
This decision will accelerate growth for both its pharma & consumer healthcare businesses in India
The additional $50 million will go towards venture capital firms that specialize in near- and long-term healthcare solutions for patients in low- and middle-income countries
Subscribe To Our Newsletter & Stay Updated